Ultragenyx Pharmaceutical Market Sentiment

Ultragenyx Pharmaceutical Inc

RARENASDAQ

Trade with Public

$15.09

0.020.13%

最終更新: Oct 20, 9:30 AM

$15.09

0.020.13%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Ultragenyx Pharmaceutical Market Sentiment

Market sentiment signals for Ultragenyx Pharmaceutical (RARE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 21.4% short float

Options Flow▲ 0.05 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

28 analysts

Options Flow (P/C)

0.05

More calls — Bullish

979 calls · 51 puts

Avg Consensus PT

$47

+210.2%

Highest Price Target

$140

+827.8%

Piper Sandler

Lowest Price Target

$16

+6.0%

UBS

Short Interest

21.4%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 15, 2026	UBS	Joon Lee—	+6.0%	$16	Initiate	Neutral
Sep 21, 2026	Evercore ISI Group	Liisa Bayko—	+19.3%	$16 → $18	Maintained	In-Line
Sep 21, 2026	Barclays	Eliana Merle—	+131.9%	$32 → $35	Maintained	Overweight
Sep 18, 2026	Morgan Stanley	Maxwell Skor—	+32.5%	$18 → $20	Maintained	Equal-Weight
Sep 18, 2026	Citigroup	Yigal Nochomovitz—	+112.1%	$31 → $32	Maintained	Buy
Sep 18, 2026	Canaccord Genuity	Whitney Ijem—	+158.4%	$37 → $39	Maintained	Buy
Sep 18, 2026	Cantor Fitzgerald	Kristen Kluska—	+158.4%	$33 → $39	Maintained	Overweight
Sep 17, 2026	Citigroup	Yigal Nochomovitz—	+105.4%	$28 → $31	Maintained	Buy
Sep 4, 2026	Goldman Sachs	Salveen Richter—	+25.9%	$28 → $19	Maintained	Neutral
Sep 4, 2026	Barclays	Eliana Merle—	+112.1%	$43 → $32	Maintained	Overweight
Sep 3, 2026	JP Morgan	Anupam Rama—	+138.6%	$80 → $36	Downgrade	Overweight→Neutral
Sep 3, 2026	Jefferies	Maury Raycroft—	+85.6%	$77 → $28	Maintained	Buy
Sep 3, 2026	William Blair	Sami Corwin—	—	—	Downgrade	Outperform→Market Perform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+85.6%	$58 → $28	Maintained	Buy
Sep 3, 2026	TD Cowen	Yaron Werber—	+19.3%	$49 → $18	Maintained	Buy
Sep 3, 2026	Wells Fargo	Benjamin Burnett—	+19.3%	$50 → $18	Maintained	Overweight
Sep 3, 2026	Canaccord Genuity	Whitney Ijem—	+145.2%	$83 → $37	Maintained	Buy
Sep 3, 2026	Wedbush	Laura Chico—	+52.4%	$30 → $23	Maintained	Neutral
Sep 3, 2026	Evercore ISI Group	Liisa Bayko—	+6.0%	$34 → $16	Downgrade	Outperform→In-Line
Sep 3, 2026	Baird	Joel Beatty—	+6.0%	$40 → $16	Downgrade	Outperform→Neutral
Sep 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+65.7%	$50 → $25	Maintained	Buy
Sep 3, 2026	Cantor Fitzgerald	Kristen Kluska—	+118.7%	$103 → $33	Maintained	Overweight
Aug 28, 2026	Wells Fargo	Michael Turrin—	+231.3%	$46 → $50	Maintained	Overweight
Aug 25, 2026	JP Morgan	Anupam Rama—	+430.2%	$75 → $80	Maintained	Overweight
Aug 21, 2026	Morgan Stanley	Jeffrey Hung—	+390.4%	$67 → $74	Maintained	Overweight